More tools:Markets·Screener·Research·Chat

ProMIS Neurosciences Inc. Common Shares (ON) (PMN) Financial Statements

ProMIS Neurosciences Inc. Common Shares (ON)
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SMDG62
XNAS · usd
12.53▼ 0.07 (-0.56%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value—
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA—
Diluted EPS (TTM)
EBITDA Margin—
Net Debt—
Trading Information
Previous Close12.60
Day's Range12.27 – 13.13
52-Week Range0.29 – 27.40
Volume38.0K
Avg Volume96.9K
Share Statistics
Shares Outstanding
Employees11
ExchangeXNAS
Listed2005-09-30
Share count as of August 13, 2026
Loading Income Statement…
Key questions about ProMIS Neurosciences Inc. Common Shares (ON) (PMN)
What is ProMIS Neurosciences Inc. Common Shares (ON)'s Market Cap?
ProMIS Neurosciences Inc. Common Shares (ON)'s Market Cap is $112.4M, based on as-reported figures from SEC (XBRL) filings.
What is ProMIS Neurosciences Inc. Common Shares (ON)'s Net Income (TTM)?
ProMIS Neurosciences Inc. Common Shares (ON)'s Net Income (TTM) is -$42.2M, based on as-reported figures from SEC (XBRL) filings.
What is ProMIS Neurosciences Inc. Common Shares (ON)'s Diluted EPS (TTM)?
ProMIS Neurosciences Inc. Common Shares (ON)'s Diluted EPS (TTM) is -4.71, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income
Net loss
Net loss per share, basic (in dollars per share)—
Net loss per share, diluted (in dollars per share)—